title: Incidence and clinical features of cerebrovascular disease among HIV-infected adults in the Southeastern United States.
abstract: With aging of the HIV-infected population, non-AIDS conditions such as cardiovascular disease (CVD) now account for substantial mortality and morbidity. While myocardial infarction is the major outcome of interest in the field of HIV and CVD, cerebrovascular disease remains understudied, especially in the Southeastern United States. We determined the incidence and clinical features of cerebrovascular events (CVE) in a large HIV clinical cohort in North Carolina (NC). A total of 2,515 HIV-infected adults contributed a median of 4.5 years (IQR: 2.0, 7.8) of follow-up. Fifty-three CVEs were adjudicated for an incidence rate of 3.87 per 1,000 person-years (95% CI: 2.90, 5.06). The ischemic stroke incidence was 2.26 per 1,000 person-years (95% CI: 1.53, 3.21), approximately 1.5 times the rate of a population-based cohort in NC. At the time of CVE, the median age was 48 years (IQR: 42, 55). Of ischemic strokes 76% resulted from large artery atherosclerosis or small vessel (lacunar) disease. In multivariable analyses, age, hypertension, dyslipidemia, recent CD4(+) cell count ≤200 cells/mm(3), and recent HIV RNA >400 copies/ml were associated with an increased risk of CVE. Antiretroviral therapy (ART) was not associated with the risk of CVE. We concluded that in the post-ART era, HIV-infected individuals appear to be at moderately increased risk of stroke. Prevention of CVEs in this population will require modification of traditional CVD risk factors and early, effective treatment of HIV infection.
authors.affiliation: Department of Medicine, University of North Carolina, Chapel Hill, NC 27599-7030, USA.
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Vinikoor
authors.forename: Sonia
authors.initials: S
authors.lastname: Napravnik
authors.forename: Michelle
authors.initials: M
authors.lastname: Floris-Moore
authors.forename: Susan
authors.initials: S
authors.lastname: Wilson
authors.forename: David Y
authors.initials: DY
authors.lastname: Huang
authors.forename: Joseph J
authors.initials: JJ
authors.lastname: Eron
mesh_terms: D000328:Adult; D002561:Cerebrovascular Disorders / Q000150:complications* / Q000453:epidemiology* / Q000209:etiology; D015331:Cohort Studies; D005260:Female; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D009657:North Carolina / Q000453:epidemiology; D012307:Risk Factors; D015144:Southeastern United States / Q000453:epidemiology; D020521:Stroke / Q000150:complications / Q000453:epidemiology / Q000209:etiology
references.citation: AIDS. 2009 Aug 24;23(13):1743-53
references.pmid: 19571723
references.citation: Am J Pathol. 2008 Apr;172(4):1100-11
references.pmid: 18310503
references.citation: Ann Intern Med. 1999 Mar 16;130(6):461-70
references.pmid: 10075613
references.citation: Cerebrovasc Dis. 2009;27(6):559-63
references.pmid: 19390181
references.citation: Ann Neurol. 2004 Mar;55(3):320-8
references.pmid: 14991809
references.citation: J Acquir Immune Defic Syndr. 2012 Aug 1;60(4):351-8
references.pmid: 22580566
references.citation: AIDS Care. 2006;18 Suppl 1:S45-50
references.pmid: 16938674
references.citation: AIDS. 2011 Aug 24;25(13):1637-46
references.pmid: 21646903
references.citation: HIV Clin Trials. 2010 Jul-Aug;11(4):205-19
references.pmid: 20974576
references.citation: N Engl J Med. 2003 Nov 20;349(21):1993-2003
references.pmid: 14627784
references.citation: Ann Intern Med. 2006 Sep 19;145(6):397-406
references.pmid: 16983127
references.citation: AIDS. 2004 Sep 3;18(13):1811-7
references.pmid: 15316342
references.citation: Stroke. 1996 Mar;27(3):538-43
references.pmid: 8610326
references.citation: AIDS. 2003 May 23;17(8):1179-93
references.pmid: 12819520
references.citation: Stroke. 1998 Aug;29(8):1602-4
references.pmid: 9707200
references.citation: Stroke. 1999 Apr;30(4):736-43
references.pmid: 10187871
references.citation: Clin Infect Dis. 2010 May 15;50(10):1387-96
references.pmid: 20380565
references.citation: Stroke. 1994 Dec;25(12):2348-55
references.pmid: 7974572
references.citation: Stroke. 2009 Jun;40(6):2276-93
references.pmid: 19423857
references.citation: Kidney Int. 2005 Jun;67(6):2089-100
references.pmid: 15882252
references.citation: Neurology. 2011 Feb 1;76(5):444-50
references.pmid: 21248273
references.citation: Circulation. 1999 Aug 17;100(7):700-5
references.pmid: 10449690
references.citation: J Acquir Immune Defic Syndr. 2012 Jul 1;60(3):265-72
references.pmid: 22531756
references.citation: PLoS Med. 2007 Jan;4(1):e43
references.pmid: 17411317
references.citation: AIDS. 2010 Jul 31;24(12):1877-86
references.pmid: 20588170
references.citation: Neurology. 2007 Apr 17;68(16):1257-61
references.pmid: 17438215
references.citation: Stroke. 2000 Sep;31(9):2117-26
references.pmid: 10978040
references.citation: Arch Intern Med. 2005 May 23;165(10):1179-84
references.pmid: 15911733
references.citation: N Engl J Med. 2006 Nov 30;355(22):2283-96
references.pmid: 17135583
references.citation: J Neurol Neurosurg Psychiatry. 2007 Dec;78(12):1320-4
references.pmid: 17470469
references.citation: J Clin Epidemiol. 1988;41(2):105-14
references.pmid: 3335877
references.citation: Eur J Neurol. 2006 Jun;13(6):581-98
references.pmid: 16796582
references.citation: Stroke. 1993 Jan;24(1):35-41
references.pmid: 7678184
references.citation: J Clin Endocrinol Metab. 2007 Jul;92(7):2506-12
references.pmid: 17456578